Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) Short Interest Up 23.2% in March
by Amy Steele · The Cerbat GemNeonc Technologies Holdings, Inc. (NASDAQ:NTHI – Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling 289,781 shares, an increase of 23.2% from the March 15th total of 235,277 shares. Based on an average trading volume of 32,581 shares, the short-interest ratio is currently 8.9 days.
Neonc Technologies Stock Performance
Shares of Neonc Technologies stock traded up $0.32 during trading on Friday, reaching $5.34. The company’s stock had a trading volume of 23,357 shares, compared to its average volume of 52,664. The company has a 50-day moving average price of $8.14 and a two-hundred day moving average price of $8.88. Neonc Technologies has a fifty-two week low of $3.20 and a fifty-two week high of $12.99.
Analysts Set New Price Targets
NTHI has been the subject of several analyst reports. Zacks Research upgraded shares of Neonc Technologies to a “hold” rating in a report on Wednesday, January 14th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neonc Technologies in a report on Friday, March 27th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce”.
Check Out Our Latest Stock Report on NTHI
Insider Activity
In other Neonc Technologies news, President Amir F. Heshmatpour purchased 10,000 shares of the business’s stock in a transaction on Friday, April 10th. The shares were bought at an average cost of $4.89 per share, for a total transaction of $48,900.00. Following the completion of the purchase, the president directly owned 3,042,000 shares of the company’s stock, valued at approximately $14,875,380. This trade represents a 0.33% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last quarter, insiders have purchased 50,200 shares of company stock valued at $285,350.
Institutional Trading of Neonc Technologies
Several hedge funds have recently made changes to their positions in NTHI. Barclays PLC grew its holdings in shares of Neonc Technologies by 5,314.8% in the 4th quarter. Barclays PLC now owns 9,151 shares of the company’s stock worth $76,000 after acquiring an additional 8,982 shares during the period. Foundations Investment Advisors LLC purchased a new position in shares of Neonc Technologies in the third quarter valued at $100,000. SLT Holdings LLC acquired a new position in shares of Neonc Technologies during the 3rd quarter worth $100,000. Goldman Sachs Group Inc. purchased a new stake in shares of Neonc Technologies in the 4th quarter worth about $124,000. Finally, OMERS ADMINISTRATION Corp acquired a new stake in Neonc Technologies in the 4th quarter valued at about $126,000.
Neonc Technologies Company Profile
Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.